LATISSE ® is the only prescription eyelash product approved in Canada to grow your natural eyelashes longer, fuller, and darker. Unlike over-the-counter eyelash products that condition and moisturize lashes, or mascara products that make your lashes look longer than they are, LATISSE® has been clinically proven to actually increase lash growth.
LATISSE® is the first and only FDA-approved prescription treatment for inadequate or not enough eyelashes, growing them longer, fuller and darker.
LATISSE® solution is a once-nightly treatment you apply topically to the base of your upper eyelashes, as instructed by your doctor. Then, gradually, the results come in. You may start to see more length in as little as 4 weeks and you should achieve full growth in 16 weeks. It’s not an illusion of growth. It’s real lash growth.
LATISSE® makes lash growth possible because of its active ingredient: bimatoprost. Although the precise mechanism of action is unknown, LATISSE® is believed to affect the growth (anagen) phase of the eyelash hair cycle in two ways: first, it increases the length of this phase, and second, it increases the number of hairs in this growth phase.
Yes, there is no problem in using mascara while you are using LATISSE® .
If LATISSE® is discontinued, lashes will gradually return to their previous appearance.
The most common side effects after using LATISSE® solution are an itching sensation in the eyes and/or eye redness. These were reported in approximately 4% of patients. solution may cause other less common side effects, which typically occur on the skin close to where is applied, or in the eyes. These include skin darkening, eye irritation, eye dryness, and eyelid redness.
There have been no reports of eye color change in the LATISSE® clinical study. However, there is the potential for increased brown iris pigmentation which is likely to be permanent. Increased iris pigmentation is associated at a very low incidence when bimatropost is instilled directly into the eye.
LATISSE® may cause darkening to the upper eyelid. This is expected to be reversible if you stop using LATISSE® .